Northwest Bancshares’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.99M | Sell |
11,203
-216
| -2% | -$96.2K | 0.87% | 29 |
|
|
2025
Q1 | $5.54M | Sell |
11,419
-302
| -3% | -$146K | 1.02% | 21 |
|
|
2024
Q4 | $4.72M | Sell |
11,721
-1,404
| -11% | -$565K | 0.87% | 28 |
|
|
2024
Q3 | $6.1M | Sell |
13,125
-2,683
| -17% | -$1.25M | 1.04% | 25 |
|
|
2024
Q2 | $7.41M | Sell |
15,808
-567
| -3% | -$266K | 1.26% | 20 |
|
|
2024
Q1 | $6.84M | Sell |
16,375
-527
| -3% | -$220K | 1.08% | 29 |
|
|
2023
Q4 | $6.88M | Sell |
16,902
-179
| -1% | -$72.8K | 1.25% | 20 |
|
|
2023
Q3 | $5.94M | Sell |
17,081
-610
| -3% | -$212K | 1.14% | 19 |
|
|
2023
Q2 | $6.23M | Sell |
17,691
-753
| -4% | -$265K | 1.13% | 21 |
|
|
2023
Q1 | $5.81M | Buy |
18,444
+357
| +2% | +$112K | 1.12% | 21 |
|
|
2022
Q4 | $5.22M | Sell |
18,087
-3,497
| -16% | -$1.01M | 1.05% | 26 |
|
|
2022
Q3 | $6.25M | Buy |
21,584
+49
| +0.2% | +$14.2K | 1.46% | 10 |
|
|
2022
Q2 | $6.07M | Sell |
21,535
-509
| -2% | -$143K | 1.37% | 12 |
|
|
2022
Q1 | $5.75M | Sell |
22,044
-1,401
| -6% | -$366K | 1.11% | 17 |
|
|
2021
Q4 | $5.15M | Buy |
23,445
+1,079
| +5% | +$237K | 1.01% | 27 |
|
|
2021
Q3 | $4.06M | Buy |
22,366
+979
| +5% | +$178K | 0.92% | 42 |
|
|
2021
Q2 | $4.31M | Buy |
21,387
+3,834
| +22% | +$773K | 0.98% | 37 |
|
|
2021
Q1 | $3.77M | Buy |
+17,553
| New | +$3.77M | 0.89% | 44 |
|